Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genotype 1 Hepatitis C Virus”

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01425190
What this trial is testing

Pharmacokinetics of Boceprevir in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P07614)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 16
Post-approval studies (Phase 4)Study completedNCT01447420
What this trial is testing

Sustained Virological Response in Relation to IL28-b Expression in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1 on Combination Treatment With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 129
Testing effectiveness (Phase 2)Study completedNCT00475176
What this trial is testing

S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 24
Not applicableStudy completedNCT02508090
What this trial is testing

Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C (CHC) Who Have Not Responded to Pegylated-Interferon Alpha Plus Ribavirin

Who this might be right for
Chronic Hepatitis C
Hoffmann-La Roche 10
Testing effectiveness (Phase 2)Study completedNCT00984620
What this trial is testing

Short Term Treatment With BI 201335, Peginterferon-alpha 2a and Ribavirin in Hepatitis c Virus Genotype-1 Treatment-naïve Patients (SILEN-C3)

Who this might be right for
Hepatitis C
Boehringer Ingelheim 160
Large-scale testing (Phase 3)Study completedNCT01498068
What this trial is testing

Open-Label, Bridging Study of Telaprevir in Treatment-Naïve and Treatment-Experienced Russian Patients With Genotype 1 Chronic Hepatitis C

Who this might be right for
Genotype 1 Chronic Hepatitis C
Janssen-Cilag International NV 36
Not applicableWithdrawnNCT00876174
What this trial is testing

Effects of Genotypes on Interferon Signaling in Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
University of Nebraska
Testing effectiveness (Phase 2)Study completedNCT01749150
What this trial is testing

Ritonavir-Boosted Danoprevir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients of Asian Origin With Chronic Hepatitis C Genotype 1 With or Without Cirrhosis

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 61
Large-scale testing (Phase 3)Ended earlyNCT01446250
What this trial is testing

Alisporivir (Deb025) and Boceprevir Triple Therapies in African American Participants Not Previously Treated for Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C
Debiopharm International SA 8
Large-scale testing (Phase 3)Study completedNCT02705534
What this trial is testing

Sofosbuvir, Ledipasvir, Ribavirin for Hepatitis C Cirrhotics, Genotype 1

Who this might be right for
Hepatitis CCirrhosis
Tehran University of Medical Sciences 50
Not applicableWithdrawnNCT02070107
What this trial is testing

Technology-Based Application To Improve The Triple Therapy Adherence Rate In Subjects With Hepatitis C Infection

Who this might be right for
Hepatitis C
University of Louisville
Not applicableStudy completedNCT01508130
What this trial is testing

An Observational Study of Peginterferon (e.g. Pegasys)-Based Direct Acting Antiviral Triple Therapy in Patients With Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 672
Testing effectiveness (Phase 2)Study completedNCT01185028
What this trial is testing

A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures

Who this might be right for
Hepatitis C InfectionHIV Infection
National Institutes of Health Clinical Center (CC) 8
Large-scale testing (Phase 3)Ended earlyNCT01821963
What this trial is testing

Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)

Who this might be right for
Infection
M.D. Anderson Cancer Center 1
Post-approval studies (Phase 4)Study completedNCT01937728
What this trial is testing

Tailored Regimens of PEGASYS® and Ribavirin for Genotype 1 Chronic Hepatitis C Patients Trial (TARGET-1)

Who this might be right for
Hepatitis C
Kaohsiung Medical University Chung-Ho Memorial Hospital 542
Large-scale testing (Phase 3)Study completedNCT01854528
What this trial is testing

Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) for Treatment of Chronic Hepatitis C Infection in Treatment-experienced Adults

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 148
Not applicableStudy completedNCT00728494
What this trial is testing

Compliance of HCV Genotype 1 Infected Patients Receiving PegIntron/Rebetol and a Patient Assistance Program (Study P04671)

Who this might be right for
Hepatitis C, ChronicHepatitis C
Merck Sharp & Dohme LLC 99
Testing effectiveness (Phase 2)Study completedNCT04246723
What this trial is testing

Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Sofosbuvir in Treatment-naïve Patients With Chronic Hepatitis C Genotype 1

Who this might be right for
Chronic Hepatitis c Genotype 1
R-Pharm 85
Testing effectiveness (Phase 2)WithdrawnNCT00895882
What this trial is testing

Study to Evaluate Different Regimens of Vaniprevir (MK7009) for the Treatment of Chronic Genotype 1 Hepatitis C Virus Infection in Treatment-naive Patients (MK-7009-019)(WITHDRAWN)

Who this might be right for
Chronic Genotype 1 Hepatitis C Virus Infection
Merck Sharp & Dohme LLC
Large-scale testing (Phase 3)Study completedNCT01389323
What this trial is testing

BMS-790052 (Daclatasvir) Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 448
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation